{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:47:03Z","timestamp":1772164023515,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Depression is a kind of chronic and recurrent mental disorder, the main clinical characteristics of the patients are marked and persistent depression. At the same time, it is often accompanied by chronic physical disease, cognitive impairment, and functional damage, which is one of the common diseases that seriously threaten human health. At present, 3 kinds of oral Chinese patent medicine have clinical comparability in the treatment of depression of liver stagnation and spleen deficiency, but there is no evidence for clinical efficacy and safety. Therefore, this study aims to integrate the clinical related syndromes of direct and indirect comparison by using systematic evaluation and network meta-analysis (NMA). According to the data, the different Chinese patent medicines with the same evidence body for the treatment of the disease are collected, analyzed, and sequenced in a quantitative and comprehensive way, and then the advantages and disadvantages of the efficacy and safety between different Chinese patent medicines are screened out to get the best choice scheme, thus providing reference value and evidence-based theoretical evidence for the clinical optimization of drug selection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Comprehensive retrieval of China National Knowledge Infrastructure, Chinese scientific journal database (VIP), China biological feature database (CBM) and WANFANG Data Chinese electronic database and the Cochrane Library, PubMed, Web of Science, and EMBASE foreign database. Search and publish the clinical randomized controlled trials of these 3 Chinese patent medicines combined with fluoxetine compared with fluoxetine. The retrieval time is from the establishment of the database to October 31, 2019. The 2 first authors will screen the literatures that meet the inclusion criteria, extract the data independently according to the predesigned rules, and evaluate the literature quality and bias risk of the included research according to the Cochrane 5.1 manual standard. R and Aggregate Data Drug Information System software were used for data consolidation and NMA to evaluate the ranking probability of all interventions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This result will show that the best oral Chinese patent medicine to assist the treatment of liver stagnation and spleen deficiency depression provides reliable evidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study will provide systematic evidence-based medicine evidence for TCM assisted treatment of depression of liver stagnation and spleen deficiency type, and help clinicians, patients with depression and decision-makers to make more effective, safer, and economic optimal treatment plan in the decision-making process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PROSPERO registration number:<\/jats:title>\n            <jats:p>CRD42019115695.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019142","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:10:43Z","timestamp":1581538243000},"page":"e19142","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression"],"prefix":"10.1097","volume":"99","author":[{"given":"Ying","family":"Yu","sequence":"first","affiliation":[{"name":"2018 Level Doctor's Degree Graduate Class"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gong","family":"Zhang","sequence":"additional","affiliation":[{"name":"2017 Level Doctor's Degree Graduate Class, College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[{"name":"Graduate Office of Shandong University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailiang","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,2]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1126\/science.288.5463.39","article-title":"Mental health: global survey examines impact of depression","volume":"288","author":"Holden","year":"2000","journal-title":"Science (New York, NY)"},{"key":"R2-20230915","first-page":"1517","article-title":"Depression is the leading cause of disability around the world","volume":"317","author":"Friedrich","year":"2017","journal-title":"JAMA"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/1028415X.2015.1103461","article-title":"Natural products, micronutrients, and nutraceuticals for the treatment of depression: a short review","volume":"20","author":"Nabavi","year":"2017","journal-title":"Nutr Neurosci"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/sj.mp.4001525","article-title":"SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression","volume":"9","author":"Zill","year":"2004","journal-title":"Mol Psychiatry"},{"key":"R5-20230915","first-page":"50","article-title":"Research overview of antidepressants in the treatment of depression","volume":"18","author":"Xiaodang","year":"2018","journal-title":"The World's latest medical information abstract"},{"key":"R6-20230915","first-page":"84","article-title":"Pathogenesis of depression and research progress of 5-hydroxytryptamine reuptake inhibitor","volume":"19","author":"Yuhan","year":"2019","journal-title":"The world's latest medical information abstract"},{"key":"R7-20230915","first-page":"1927","article-title":"Network meta-analysis of traditional Chinese medicine in the treatment of coronary heart disease and angina pectoris","volume":"44","author":"Zhaochen","year":"2019","journal-title":"Chin J Trad Med"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"R10-20230915","first-page":"i4086","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"354","year":"2016","journal-title":"BMJ"},{"key":"R11-20230915","first-page":"147","article-title":"Application of Cochrane bias risk assessment tool in meta-analysis of randomized controlled study","volume":"29","author":"Hongqiu","year":"2014","journal-title":"China Circ J"},{"key":"R12-20230915","first-page":"417","article-title":"Application and comparison of Jadad scale and Cochrane bias risk assessment tool in quality evaluation of randomized controlled trials","volume":"10","author":"Jie","year":"2012","journal-title":"Chin J Oral Maxillofac Surg"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000502293","article-title":"Lifestyle interventions for weight management in people with serious mental illness: a systematic review with meta-analysis, trial sequential analysis, and meta-regression analysis exploring the mediators and moderators of treatment effects","volume":"88","author":"Speyer","year":"2019","journal-title":"Psychother Psychosom"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jclinepi.2016.01.003","article-title":"The quality of evidence in Chinese meta-analyses needs to be improved","volume":"74","author":"Yao","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R15-20230915","first-page":"241","article-title":"R software calls JAGS software to realize network meta-analysis","volume":"14","author":"Chao","year":"2014","journal-title":"Chin J Evid Based Med"},{"key":"R16-20230915","first-page":"55","article-title":"ADDIS: a decision support system for evidence-based medicine %","author":"Van Valkenhoef","year":"2013","journal-title":"J Decision Support Syst"},{"key":"R17-20230915","first-page":"1508","article-title":"Using ADDIS software to realize network meta analysis","volume":"13","author":"Xiantao","year":"2013","journal-title":"Chin J Evid Based Med"},{"key":"R18-20230915","first-page":"1115","article-title":"Heterogeneity and its treatment in meta analysis","volume":"9","author":"Dan","year":"2009","journal-title":"Chin J Evid Based Med"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S2215-0366(19)30403-1","article-title":"School-based interventions to prevent anxiety and depression in children and young people: a systematic review and network meta-analysis","volume":"6","author":"Caldwell","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"R20-20230915","first-page":"877","article-title":"Research progress on the mechanism of traditional Chinese medicine in the treatment of depression","author":"Qingqiu","year":"2007","journal-title":"J Trad Chin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:10:55Z","timestamp":1694819455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019142"}},"subtitle":["A protocol for systematic review"],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019142","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}